CANNAPHARMARX, INC. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/97792f61-eac0-46b6-8c3d-e2020a38222e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.4M | 2025-01-01 – 2025-12-31 | evidence 0001654954-26-003108 |
| FY 2024 | $820.1k | 2024-01-01 – 2024-12-31 | evidence 0001654954-25-004122 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001654954-25-004122 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001683168-23-006237 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001683168-22-002703 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001683168-21-001389 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001683168-20-001748 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001683168-19-000940 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001683168-18-002744 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001683168-18-002736 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001683168-18-002697 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-113552 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-113552 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CANNAPHARMARX, INC. — all facts · Net Income · Operating Income